SCHEMBL1004196

SCHEMBL1004196

NC(=O)C(O)CCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.50
ERAP1 Q9NZ08 2/20 0.50
ERAP2 Q6P179 1/20 0.50
METAP2 P50579 1/20 0.47
METAP1 P53582 1/20 0.47
CNR2 P34972 1/20 0.47
TRPA1 O75762 1/20 0.47
TSHR P16473 1/20 0.47
EPHX1 P07099 1/20 0.47
KEAP1 Q14145 1/20 0.47
DPP4 P27487 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP12 P39900 1/20 0.46
MMP13 P45452 1/20 0.46
MMP14 P50281 1/20 0.46
LMNA P02545 1/20 0.46
FAAH O00519 1/20 0.46
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021775 0.89 GRIK1 (0.53) TRPA1EPHX1LMNAFAAHSMN1; SMN2
SCHEMBL865266 0.85 FAAH (0.58) TRPA1LMNAFAAHSMN1; SMN2
SCHEMBL5135541 0.85 FAAH (0.58) TRPA1LMNAFAAHSMN1; SMN2
SCHEMBL233441 0.83 CNR2 (0.50) ANPEPERAP1ERAP2CNR2TSHR
SCHEMBL360781 0.83 CNR2 (0.50) ANPEPERAP1ERAP2CNR2TSHR
SCHEMBL233440 0.83 CNR2 (0.50) ANPEPERAP1ERAP2CNR2TSHR
Aminomethylamide SCHEMBL11027400 0.82 CNR2 (0.46) ANPEPERAP1ERAP2METAP2METAP1
SCHEMBL27859674 0.82 CNR2 (0.49) ANPEPERAP1ERAP2CNR2TSHR
SCHEMBL28107772 0.82 ERAP1 (0.52) ANPEPERAP1ERAP2CNR2TSHR
SCHEMBL341788 0.82 ANPEP (0.52) ANPEPERAP1ERAP2CNR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112368263-B Dipeptidyl ketoamide m-methoxyphenyl derivative and application thereof 兰德施泰纳根梅德公司 2023-09-26 CN disclosed
WO-2020141734-A1 METHOD FOR PREPARING CHIRAL GAMMA-LACTAM COMPOUND AND METAL COMPLEX THEREFOR 기초과학연구원 2020-07-09 WO disclosed
EP-2762565-B1 NOVEL AMIDASE KANEKA CORP (JP) 2016-11-30 EP disclosed
US-9493762-B2 Vector, a transformant and a method to produce a polypeptide having activity to selectively hydrolyze a (R)-tropic acid amide in a racemic mixture KANEKA CORPORATION (JP) 2016-11-15 US disclosed
US-20140335575-A1 NOVEL AMIDASE KANEKA CORPORATION (JP) 2014-11-13 US disclosed
EP-2762565-A1 NOVEL AMIDASE Kaneka Corporation (JP) 2014-08-06 EP disclosed
US-8778219-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2014-07-15 US disclosed
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES UT-BATTELLE, LLC (US) 2013-12-19 US disclosed
US-8535560-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2013-09-17 US disclosed
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 WO disclosed
WO-2011008664-A2 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES UT-BATTELLE, LLC (US) 2011-01-20 WO disclosed
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures UT-BATTELLE, LLC (US) 2011-01-20 US disclosed
EP-0666320-B1 Process for producing alpha-hydroxy acid or alpha-hydroxyamide by microorganisms MITSUBISHI RAYON CO (JP) 2000-12-20 EP disclosed
US-5508181-A REACTING AN ALPHA-HYDROXYNITRILE (OR MIXTURE WITH AN ALDEHYDE) WITH HYDROGEN CYANIDE IN PRESENCE OF PHOSPHITE OR HYPOPHOSPHITE IONS NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1996-04-16 US disclosed
EP-0666320-A2 Process for producing alpha-hydroxy acid or alpha-hydroxyamide by microorganisms NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1995-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338389-A1 IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES POU2F1, POU2F2, POF1B ANPEP 3456/4885ERAP1 4666/4885ERAP2 4414/4885
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures POU2F1, POU2F2, POF1B ANPEP 3456/4885ERAP1 4666/4885ERAP2 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.